Skip to main content
Erschienen in: Archives of Virology 11/2017

22.06.2017 | Original Article

Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin

verfasst von: Dalia S. Elhelw, Sarah E. Riad, Heba Shawer, Nada El-Ekiaby, Ayman Salah, Abdelrahman Zekri, Asma Amleh, Gamal Esmat, Ahmed Ihab Abdelaziz

Erschienen in: Archives of Virology | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

Occludin (OCLN) is an essential factor for HCV entry through interacting with other surface receptors. The aim of this study was to investigate the epigenetic regulation of Occludin expression and to study its impact on viral infectivity. microRNAs expression was assessed using qRT-PCR, while OCLN protein expression was investigated by indirect immunofluorescence and Western blotting. Viral infectivity was assessed by measuring viral-load using qRT-PCR. In silico analysis predicted that miR-200c targeted the OCLN 3’UTR, which was further experimentally confirmed. miR-122 was previously validated to target the 3’UTR of OCLN and was used as a control. We report a significant down-regulation of miR-200c in liver tissues of HCV-infected patients. Ectopic expression of both miR-122 and miR-200c in Huh7 cells reduced OCLN mRNA and protein levels. Viral infectivity was significantly reduced by miR-200c but enhanced by miR-122. This work sheds light on miR-200c as a novel regulator of HCV infectivity through the regulation of OCLN.
Literatur
1.
Zurück zum Zitat Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S et al (1993) Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123(6 Pt 2):1777–1788CrossRefPubMed Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S et al (1993) Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123(6 Pt 2):1777–1788CrossRefPubMed
5.
8.
Zurück zum Zitat Benedicto I, Molina-Jimenez F, Bartosch B, Cosset FL, Lavillette D, Prieto J et al (2009) The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection. J Virol 83(16):8012–8020. doi:10.1128/JVI.00038-09 CrossRefPubMedPubMedCentral Benedicto I, Molina-Jimenez F, Bartosch B, Cosset FL, Lavillette D, Prieto J et al (2009) The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection. J Virol 83(16):8012–8020. doi:10.​1128/​JVI.​00038-09 CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Sendi H, Mehrab-Mohseni M, Foureau DM, Ghosh S, Walling TL, Steuerwald N et al (2015) MiR-122 decreases HCV entry into hepatocytes through binding to the 3’ UTR of OCLN mRNA. Liver Int 35(4):1315–1323. doi:10.1111/liv.12698 CrossRefPubMed Sendi H, Mehrab-Mohseni M, Foureau DM, Ghosh S, Walling TL, Steuerwald N et al (2015) MiR-122 decreases HCV entry into hepatocytes through binding to the 3’ UTR of OCLN mRNA. Liver Int 35(4):1315–1323. doi:10.​1111/​liv.​12698 CrossRefPubMed
13.
Zurück zum Zitat Liu S, Yang W, Shen L, Turner JR, Coyne CB, Wang T (2009) Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J Virol 83(4):2011–2014. doi:10.1128/JVI.01888-08 CrossRefPubMed Liu S, Yang W, Shen L, Turner JR, Coyne CB, Wang T (2009) Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J Virol 83(4):2011–2014. doi:10.​1128/​JVI.​01888-08 CrossRefPubMed
14.
Zurück zum Zitat Oliveira KG, Malta FM, Nastri AC, Widman A, Faria PL, Santana RA et al (2016) Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3. Med Microbiol Immunol 205(2):111–117. doi:10.1007/s00430-015-0431-0 CrossRefPubMed Oliveira KG, Malta FM, Nastri AC, Widman A, Faria PL, Santana RA et al (2016) Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3. Med Microbiol Immunol 205(2):111–117. doi:10.​1007/​s00430-015-0431-0 CrossRefPubMed
15.
Zurück zum Zitat Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP et al (2008) MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47(4):1223–1232. doi:10.1002/hep.22158 CrossRefPubMed Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP et al (2008) MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47(4):1223–1232. doi:10.​1002/​hep.​22158 CrossRefPubMed
16.
Zurück zum Zitat Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, Voros D (2013) Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog 52(4):297–303. doi:10.1002/mc.21864 CrossRefPubMed Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, Voros D (2013) Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog 52(4):297–303. doi:10.​1002/​mc.​21864 CrossRefPubMed
17.
Zurück zum Zitat Liu Z, Yi J, Ye R, Liu J, Duan Q, Xiao J et al (2015) miR-144 regulates transforming growth factor-beta1 iduced hepatic stellate cell activation in human fibrotic liver. Int J Clin Exp Pathol 8(4):3994–4000PubMedPubMedCentral Liu Z, Yi J, Ye R, Liu J, Duan Q, Xiao J et al (2015) miR-144 regulates transforming growth factor-beta1 iduced hepatic stellate cell activation in human fibrotic liver. Int J Clin Exp Pathol 8(4):3994–4000PubMedPubMedCentral
Metadaten
Titel
Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin
verfasst von
Dalia S. Elhelw
Sarah E. Riad
Heba Shawer
Nada El-Ekiaby
Ayman Salah
Abdelrahman Zekri
Asma Amleh
Gamal Esmat
Ahmed Ihab Abdelaziz
Publikationsdatum
22.06.2017
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 11/2017
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3449-3

Weitere Artikel der Ausgabe 11/2017

Archives of Virology 11/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.